Hewlett-Packard Co. (HPQ) (HPQ) won a ruling by a California judge that Oracle Corp. (ORCL) (ORCL) is contractually obligated to continue developing software for Hewlett-Packardâs Itanium-based servers.
Both sides have 15 days to file an objection to the decision, said Judge James Kleinberg in San Jose. Oracle said in a statement that it will appeal. If the ruling stands, the lawsuit will advance to a jury trial in which Hewlett-Packard may seek $500 million in damages for breach of contract.
The judge agreed with Hewlett-Packard that Oracle made a commitment to support servers that run on Intel Corp. (INTC) (INTC)âs Itanium chips in an agreement the companies reached over Mark Hurdâs transition from chief executive officer of Hewlett-Packard to co-president of Oracle.
âThe settlement and release agreement entered into by HP, Oracle and Hurd on Sept. 20, 2010, requires Oracle to continue to offer its product suite on HPâs Itanium-based server platforms and does not confer on Oracle the discretion to decide whether to do so or not,â Kleinberg wrote.
The judge ordered the companies back in court Aug. 22 to prepare for the second phase of the case, adding that he expects them to âmeet and confer productivelyâ beforehand.
$500 Million
Before the trial started, Hewlett-Packard said it was seeking about $500 million in damages, according to a person familiar with the matter who didnât want to be identified because the damages request is confidential.
Without the order requiring Oracle to continue developing the software, Hewlett-Packard had estimated it should be awarded more than $4 billion in damages, based on an extrapolation to 2020 that accounts for projected losses, said the person.
Sales of Hewlett-Packardâs so-called business critical systems that use Itanium chips plummeted 23 percent to $421 million in the fiscal second quarter that ended in April. The company also garners services revenue from the systems that it doesnât break out.
Dave Donatelli, the companyâs executive vice president in charge of data center products, said in a recent interview the Itanium hardware decline was âallâ attributable to Oracleâs decision to stop developing software for the platform. Hewlett- Packard last November said itâs developing new systems that will offer Itanium customers a technical path to moving their applications to new systems itâs developing.
2011 Announcement
Oracleâs March 2011 announcement that it decided to stop software development for the Itanium chip came after the company âbecame convinced that Itanium was approaching its end of life and we explained our rationale to customers,â Oracle spokeswoman Deborah Hellinger said in an e-mailed statement.
Oracle, based in Redwood City, California, denied Hewlett- Packardâs claims, arguing that it never agreed to forfeit control over what software it can develop and what price it can charge.
Hewlett-Packardâs claims in the case âturns the concept of Silicon Valley âpartnershipsâ upside down,â Hellinger said in the statement. âWe plan to appeal the courtâs ruling while fully litigating our cross claims that HP misled both its partners and customers.â
âLife Supportâ
Oracle said in its cross-complaint against Hewlett-Packard that Intel âreally wanted to killâ the Itanium chip, which Oracle said was on âlife support.â
Oracle accuses Hewlett-Packard of engaging in a âcampaign of secrecy and deceptionâ and âpay-offâ to Intel to induce it to continue making the chips, according to an Oracle court filing. Those claims may be aired at the trialâs second phase.
Hewlett-Packard called todayâs ruling âa tremendous win for HP and its customers.â
âWe expect Oracle to comply with its contractual obligation as ordered by the court,â Hewlett-Packard said in an e-mailed statement.
The case is Hewlett-Packard Co. v. Oracle Corp., 11- cv-203163, California Superior Court, Santa Clara County (San Jose).
To contact the reporter on this story: Joel Rosenblatt in San Francisco at jrosenblatt@bloomberg.net
To contact the editor responsible for this story: Michael Hytha at mhytha@bloomberg.net
No comments:
Post a Comment